Development of a Modular Assay for Detailed Immunophenotyping of Peripheral Human Whole Blood Samples by Multicolor Flow Cytometry

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2016 Aug 17

PMID 27529227

Citations 42

Authors

Paul F Ruhle

Rainer Fietkau

Udo S Gaipl

Benjamin Frey

Affiliations

Soon will be listed here.

Abstract

The monitoring of immune cells gained great significance in prognosis and prediction of therapy responses. For analyzing blood samples, the multicolor flow cytometry has become the method of choice as it combines high specificity on single cell level with multiple parameters and high throughput. Here, we present a modular assay for the detailed immunophenotyping of blood (DIoB) that was optimized for an easy and direct application in whole blood samples. The DIoB assay characterizes 34 immune cell subsets that circulate the peripheral blood including all major immune cells such as T cells, B cells, natural killer (NK) cells, monocytes, dendritic cells (DCs), neutrophils, eosinophils, and basophils. In addition, it evaluates their functional state and a few non-leukocytes that also have been associated with the outcome of cancer therapy. This DIoB assay allows a longitudinal and close-meshed monitoring of a detailed immune status in patients requiring only 2.0 mL of peripheral blood and it is not restricted to peripheral blood mononuclear cells. It is currently applied for the immune monitoring of patients with glioblastoma multiforme (IMMO-GLIO-01 trial, NCT02022384), pancreatic cancer (CONKO-007 trial, NCT01827553), and head and neck cancer (DIREKHT trial, NCT02528955) and might pave the way for immune biomarker identification for prediction and prognosis of therapy outcome.

Citing Articles

Defining intra-tumoral and systemic immune biomarkers for locally advanced head-and-neck cancer - detailed protocol of a prospective, observatory multicenter trial (ImmunBioKHT) and first results of the immunophenotyping of the patients' peripheral....

Donaubauer A, Frey B, Weber M, Allner M, Vogl C, Almajali O Front Oncol. 2024; 14:1451035.

PMID: 39346733 PMC: 11427411. DOI: 10.3389/fonc.2024.1451035.

Altered IL-7 signaling in CD4+ T cells from patients with visceral leishmaniasis.

Kumar S, Bhushan Chauhan S, Upadhyay S, Singh S, Verma V, Kumar R PLoS Negl Trop Dis. 2024; 18(2):e0011960.

PMID: 38408097 PMC: 10919868. DOI: 10.1371/journal.pntd.0011960.

Effects of serial radon spa therapy on pain and peripheral immune status in patients suffering from musculoskeletal disorders- results from a prospective, randomized, placebo-controlled trial.

Donaubauer A, Becker I, Klein G, Voll R, Weikl L, Klieser M Front Immunol. 2024; 15:1307769.

PMID: 38380316 PMC: 10876773. DOI: 10.3389/fimmu.2024.1307769.

Add-on sirolimus for the treatment of mild or moderate systemic lupus erythematosus via T lymphocyte subsets balance.

Ding M, Jin L, Zhao J, Yang L, Cui S, Wang X Lupus Sci Med. 2024; 11(1).

PMID: 38351097 PMC: 10868177. DOI: 10.1136/lupus-2023-001072.

Deep Immunophenotyping of Human Whole Blood by Standardized Multi-parametric Flow Cytometry Analyses.

Gao J, Luo Y, Li H, Zhao Y, Zhao J, Han X Phenomics. 2023; 3(3):309-328.

PMID: 37325713 PMC: 10260734. DOI: 10.1007/s43657-022-00092-9.

References

Repp R, Valerius T, Sendler A, Gramatzki M, Iro H, Kalden J . Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor. Blood. 1991; 78(4):885-9. View

Salgado F, Lojo J, Vinuela J, Cordero O, Nogueira M . Interleukin-dependent modulation of HLA-DR expression on CD4and CD8 activated T cells. Immunol Cell Biol. 2002; 80(2):138-47. DOI: 10.1046/j.1440-1711.2002.01055.x. View

Fadini G, Losordo D, Dimmeler S . Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res. 2012; 110(4):624-37. PMC: 3382070. DOI: 10.1161/CIRCRESAHA.111.243386. View

Jackson S, Wilson P, James J, Capra J . Human B cell subsets. Adv Immunol. 2008; 98:151-224. DOI: 10.1016/S0065-2776(08)00405-7. View

Andre P, Castriconi R, Espeli M, Anfossi N, Juarez T, Hue S . Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors. Eur J Immunol. 2004; 34(4):961-71. DOI: 10.1002/eji.200324705. View

Crane C, Han S, Barry J, Ahn B, Lanier L, Parsa A . TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients. Neuro Oncol. 2010; 12(1):7-13. PMC: 2940557. DOI: 10.1093/neuonc/nop009. View

Fritsch R, Shen X, Sims G, Hathcock K, Hodes R, Lipsky P . Stepwise differentiation of CD4 memory T cells defined by expression of CCR7 and CD27. J Immunol. 2005; 175(10):6489-97. DOI: 10.4049/jimmunol.175.10.6489. View

Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B . Phenotypic and functional features of human Th17 cells. J Exp Med. 2007; 204(8):1849-61. PMC: 2118657. DOI: 10.1084/jem.20070663. View

Muntasell A, Magri G, Pende D, Angulo A, Lopez-Botet M . Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infection. Blood. 2010; 115(25):5170-9. DOI: 10.1182/blood-2009-11-256479. View

10.

Chen L, Zhang Z, Chen W, Zhang Z, Li Y, Shi M . B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B. J Immunol. 2007; 178(10):6634-41. DOI: 10.4049/jimmunol.178.10.6634. View

11.

Trautmann A, Ruckert B, Schmid-Grendelmeier P, Niederer E, Brocker E, Blaser K . Human CD8 T cells of the peripheral blood contain a low CD8 expressing cytotoxic/effector subpopulation. Immunology. 2003; 108(3):305-12. PMC: 1782903. DOI: 10.1046/j.1365-2567.2003.01590.x. View

12.

Andreu-Ballester J, Garcia-Ballesteros C, Benet-Campos C, Amigo V, Almela-Quilis A, Mayans J . Values for αβ and γδ T-lymphocytes and CD4+, CD8+, and CD56+ subsets in healthy adult subjects: assessment by age and gender. Cytometry B Clin Cytom. 2012; 82(4):238-44. DOI: 10.1002/cyto.b.21020. View

13.

Acosta-Rodriguez E, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A . Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol. 2007; 8(6):639-46. DOI: 10.1038/ni1467. View

14.

Guilliams M, Ginhoux F, Jakubzick C, Naik S, Onai N, Schraml B . Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat Rev Immunol. 2014; 14(8):571-8. PMC: 4638219. DOI: 10.1038/nri3712. View

15.

Barth E, Fischer G, Schneider E, Wollmeyer J, Georgieff M, Weiss M . Differences in the expression of CD64 and mCD14 on polymorphonuclear cells and on monocytes in patients with septic shock. Cytokine. 2001; 14(5):299-302. DOI: 10.1006/cyto.2001.0880. View

16.

Beavis A, Pennline K . Allo-7: a new fluorescent tandem dye for use in flow cytometry. Cytometry. 1996; 24(4):390-5. DOI: 10.1002/(SICI)1097-0320(19960801)24:4<390::AID-CYTO11>3.0.CO;2-K. View

17.

Aghaeepour N, Finak G, Hoos H, Mosmann T, Brinkman R, Gottardo R . Critical assessment of automated flow cytometry data analysis techniques. Nat Methods. 2013; 10(3):228-38. PMC: 3906045. DOI: 10.1038/nmeth.2365. View

18.

Li Y, Lee P, Sobel E, Narain S, Satoh M, Segal M . Increased expression of FcgammaRI/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus. Arthritis Res Ther. 2009; 11(1):R6. PMC: 2688236. DOI: 10.1186/ar2590. View

19.

Ravetch J, Bolland S . IgG Fc receptors. Annu Rev Immunol. 2001; 19:275-90. DOI: 10.1146/annurev.immunol.19.1.275. View

20.

Weinberg A, Song L, Wilkening C, Sevin A, Blais B, Louzao R . Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization. Clin Vaccine Immunol. 2009; 16(8):1176-86. PMC: 2725535. DOI: 10.1128/CVI.00342-08. View